Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine

Journal of Leukocyte Biology

Volumn 74, Issue 1, 2003, Pages 95-101

  Tonks, Amanda J ^a   Tonks, Alex ^a   Morris, Roger H K ^b   Jones, Kenneth P ^b   Jackson, Simon K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Immune modulation; Inflammation; Lipid; Lung

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ACETYL COENZYME A; ACYLTRANSFERASE; COENZYME A; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOPOLYSACCHARIDE; LUNG SURFACTANT; PHOSPHOLIPASE A2; PORACTANT; THROMBOCYTE ACTIVATING FACTOR; 1 ALKYLGLYCEROPHOSPHOCHOLINE ACETYLTRANSFERASE; 1-ALKYLGLYCEROPHOSPHOCHOLINE ACETYLTRANSFERASE; ARACHIDONYL TRANSACYLASE;

ARTICLE; BIOSYNTHESIS; CELL LYSATE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; ADULT RESPIRATORY DISTRESS SYNDROME; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; MEMBRANE FLUIDITY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ACETYLTRANSFERASES; ACYLTRANSFERASES; CELL LINE; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE FLUIDITY; MONOCYTES; PLATELET ACTIVATING FACTOR; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0043071561     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1202601     Document Type: Article

References (50)

1. Nagase, T., Ishii, S., Kume, K., Uozumi, N., Izumi, T., Ouchi, Y., Shimizu, T. (1999) Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104, 1071-1076.
2. Mortelliti, M. P., Manning, H. L. (2002) Acute respiratory distress syndrome. Am. Fam. Physician 65, 1823-1830.
3. Miotla, J. M., Jeffery, P. K., Hellewell, P. G. (1998) Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am. J. Respir. Cell Mol. Biol. 18, 197-204.
4. Nakos, G., Kitsiouli, E. I., Tsangaris, I., Lekka, M. E. (1998) Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS, Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med. 24, 296-303.
5. Matsumoto, K., Taki, F., Kondoh, Y., Taniguchi, H., Takagi, K. (1992) Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin. Exp. Pharmacol. Physiol. 19, 509-515.
6. Kuijpers, T. W., van der Poll, T. (1999) The role of platelet-activating factor in endotoxin related disease, In Endotoxin in Health and Disease (H. Brade et al., eds.), New York, NY, Marcel Dekker, 449-579.
7. Snyder, F. (1995) Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta 1254, 231-249.
8. Yamashita, A., Sugiura, T., Waku, K. (1997) Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. (Tokyo) 122, 1-16.
9. Held, H. D., Uhlig, S. (2000) Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am. J. Respir. Crit. Care Med. 162, 1547-1552.
10. Braquet, P., Hosford, D. (1989) The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). Prog. Clin. Biol. Res. 308, 425-439.
11. Clavijo, L. C., Carter, M. B., Matheson, P. J., Wilson, M. A., Wead, W. B., Garrison, R. N. (2001) PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. J. Appl. Physiol. 90, 261-268.
12. Prevost, M. C., Cariven, C., Chap, H. (1988) Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. Biochim. Biophys. Acta 962, 354-361.
13. Walti, H., Polla, B. S., Bachelet, M. (1997) Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr. Res. 41, 114-119.
14. Wilsher, M. L., Hughes, D. A., Haslam, P. L. (1988) Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin. Exp. Immunol. 73, 117-122.
15. Tonks, A., Morris, R. H. K., Price, A. J., Thomas, A. W., Jones, K. P., Jackson, S. K. (2001) Dipalmitoyl phosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin. Exp. Immunol. 124, 86-94.
16. Morris, R. H., Price, A. J., Tonks, A., Jackson, S. K., Jones, K. P. (2000) Prostaglandin E(2) and tumour necrosis factor-alpha release by monocytes are modulated by phospholipids. Cytokine 12, 1717-1719.
17. Speer, C. P., Gotze, B., Curstedt, T., Robertson, B. (1991) Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr. Res. 30, 69-74.
18. Veldhuizen, R., Nag, K., Orgeig, S., Possmayer, F. (1998) The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta 1408, 90-108.
19. Gunther, A., Ruppert, C., Schmidt, R., Markart, P., Grimminger, F., Walmrath, D., Seeger, W. (2001) Surfactant alteration and replacement in acute respiratory distress syndrome. Respir. Res. 2, 353-364.
20. Stafforini, D. M., Elstad, M. R., McIntyre, T. M., Zimmerman, G. A., Prescott, S. M. (1990) Human macrophages secret platelet-activating factor acetylhydrolase. J. Biol. Chem. 265, 9682-9687.
21. Altman, S. A., Randers, L., Rao, G. (1993) Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol. Prog. 9, 671-674.
22. Pinot, F., Bachelet, M., Francois, D., Polla, B. S., Walti, H. (1999) Modified natural porcine surfactant modulates tobacco smoke-induced stress response in human monocytes. Life Sci. 64, 125-134.
23. Svetlov, S. I., Liu, H., Chao, W., Olson, M. S. (1997) Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide. Biochim. Biophys. Acta 1346, 120-130.
24. Strieter, R. M., Lynch, J. P., Basha, M. A., Standiford, T. J., Kasahara, K., Kunkel, S. L. (1990) Host responses in mediating sepsis and adult respiratory distress syndrome. Semin. Respir. Infect. 5, 233-247.
25. Fink, M. P. (1998) Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. J. Antimicrob. Chemother. 41 (Suppl. A), 81-94.
26. Hayakawa, H., Myrvik, Q. N., St.Clair, R. W. (1989) Pulmonary surfactant inhibits priming of rabbit alveolar macrophage. Evidence that surfactant suppresses the oxidative burst of alveolar macrophage in infant rabbits. Am. Rev. Respir. Dis. 140, 1390-1397.
27. Rooney, S. A., Canavan, P. M., Motoyama, E. K. (1974) The identification of phosphatidylglycerol in the rat, rabbit, monkey and human lung. Biochim. Biophys. Acta 360, 56-67.
28. Bligh, E. G., Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911-917.
29. Sugatani, J., Lee, D. Y., Hughes, K. T., Saito, K. (1990) Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques. Life Sci, 46, 1443-1450.
30. Sun, X., Caplan, M. S., Hsueh, W. (1994) Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and the role of exogenous PAF. Gut 35, 215-219.
31. Winkler, J. D., Sung, C. M., Bennett, C. F., Chilton, F. H. (1991) Characterization of CoA-independent transacylase activity in U937 cells. Biochim. Biophys. Acta 1081, 339-346.
32. Darmani, H., Harwood, J. L., Jackson, S. K. (1993) Effect of interferon-gamma on membrane conformation in the macrophage-like cell line P388D. J. Interferon Res. 13, 427-431.
33. Harwood, J. L. (1987) Lung surfactant. Prog, Lipid Res. 26, 211-256.
34. Glover, R. E. (1996) Mechanisms of Endotoxin-Monocyte Interactions: An Electron Paramagnetic Resonance Study. Cardiff, UK, University of Wales College of Medicine, Ph.D. thesis.
35. Rabinovici, R., Bugelski, P. J., Esser, K. M., Hillegass, L. M., Vernick, J., Feuerstein, G. (1993) ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J. Appl. Physiol. 74, 1791-1802.
36. Jehle, R., Schlame, M., Buttner, C., Frey, B., Sinha, P., Rustow, B. (2001) Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. Biochim. Biophys. Acta 1532, 60-66.
37. Wilsher, M. L., Parker, D. J., Haslam, P. L. (1990) lmmunosuppression by pulmonary surfactant: mechanisms of action. Thorax 45, 3-8.
38. Camussi, G., Mariano, F., Biancone, L., de Martino, A., Bussolati, B., Montrucchio, G., Tobias, P. S. (1995) Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J. Immunol. 155, 316-324.
39. Geertsma, M. F., Broos, H. R., van den Barselaar, M. T., Nibbering, P. H., van Furth, R. (1993) Lung surfactant suppresses oxygen-dependent bactericidal functions of human blood monocytes by inhibiting the assembly of the NADPH oxidase. J. Immunol. 150, 2391-2400.
40. Redenti, E., Peveri, T., Ventura, P., Zanol, M., Selva, A. (1994) Characterization of phospholipidic components of the natural pulmonary surfactant Curosurf. Farmaco 49, 285-289.
41. Hidi, R., Vial, D., Havet, N., Berger, A., Vargaftig, B. B., Touqui, L. (1997) Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages. Biochem. Pharmacol. 54, 1055-1058.
42. Thomassen, M. J., Meeker, D. P., Antal, J. M., Connors, M. J., Wiedemann, H. P. (1992) Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 7, 257-260.
43. Moya, F. R., Hoffman, D. R., Zhao, B., Johnston, J. M. (1993) Platelet-activating factor in surfactant preparations. Lancet 341, 858-860.
44. Yanoshita, R., Chang, H. W., Son, K. H., Kudo, I., Samejima, Y. (1996) Inhibition of lysoPAF acetyltransferase activity by flavonoids. Inflamm. Res. 45, 546-549.
45. Winkler, J. D., Fonteh, A. N., Sung, C. M., Heravi, J. D., Nixon, A. B., Chabot-Fletcher, M., Griswold, D., Marshall, L. A., Chilton, F. H. (1995) Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators. J. Pharmacol. Exp. Ther. 274, 1338-1347.
46. Baker, P., Owen, J., Nixon, A., Thomas, L., Wooten, R., Daniel, L., O'Flaherty, J., Wykle, R. (2002) Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. Biochim. Biophys. Acta 1592, 175-184.
47. Holland, M. R., Venable, M. E., Whatley, R. E., Zimmerman, G. A., McIntyre, T. M., Prescott, S. M. (1992) Activation of the acetyl-coenzyme A: lysoplatelet-activating factor acetyltransferase regulates platelet-activating factor synthesis in human endothelial cells. J. Biol. Chem. 267, 22883-22890.
48. Wiseman, H. (1996) Dietary influences on membrane function: importance in protection against oxidative damage and disease. J. Nutr. Biochem. 7, 2-15.
49. Peck, M. D. (1994) Interaction of lipids with immune function I: biochemical effects of dietary lipids on plasma membrane. J. Nutr. Biochem. 5, 466-478.
50. Hidalgo, C. (1985) Membrane fluidity and the function of the Ca2+-ATPase of sarcoplasmic reticulum. In Cellular Aspects, vol. 4 (R. C. Aloia, J. M. Boggs, eds.), London, UK, Academic, 51-96.